Seroprevalence of Human T-Cell Lymphotropic Viruses Types 1 and 2 Antibodies in Hepatitis C Virus-Positive Patients: Manitoba, Canada, 2012–2014

Human T-cell lymphotropic viruses types 1 and 2 are probably among the most neglected blood-borne pathogens that have experienced significant changes in their epidemiology since discovery, which could be attributed to globalization and intravenous drug use practices as well as enhanced screening rec...

Descripción completa

Detalles Bibliográficos
Autores principales: Kadkhoda, Kamran, Smart, Gerry, Bacon, Diane, Casselman, Adara, Malloch, Laurie, Kim, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2014
Materias:
Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4396433/
https://www.ncbi.nlm.nih.gov/pubmed/25884009
http://dx.doi.org/10.1093/ofid/ofu122
_version_ 1782366579814563840
author Kadkhoda, Kamran
Smart, Gerry
Bacon, Diane
Casselman, Adara
Malloch, Laurie
Kim, John
author_facet Kadkhoda, Kamran
Smart, Gerry
Bacon, Diane
Casselman, Adara
Malloch, Laurie
Kim, John
author_sort Kadkhoda, Kamran
collection PubMed
description Human T-cell lymphotropic viruses types 1 and 2 are probably among the most neglected blood-borne pathogens that have experienced significant changes in their epidemiology since discovery, which could be attributed to globalization and intravenous drug use practices as well as enhanced screening recommendations; however, systematic prevalence studies, especially in high-risk populations in North America, are not updated.
format Online
Article
Text
id pubmed-4396433
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-43964332015-04-16 Seroprevalence of Human T-Cell Lymphotropic Viruses Types 1 and 2 Antibodies in Hepatitis C Virus-Positive Patients: Manitoba, Canada, 2012–2014 Kadkhoda, Kamran Smart, Gerry Bacon, Diane Casselman, Adara Malloch, Laurie Kim, John Open Forum Infect Dis Brief Reports Human T-cell lymphotropic viruses types 1 and 2 are probably among the most neglected blood-borne pathogens that have experienced significant changes in their epidemiology since discovery, which could be attributed to globalization and intravenous drug use practices as well as enhanced screening recommendations; however, systematic prevalence studies, especially in high-risk populations in North America, are not updated. Oxford University Press 2014-12-23 /pmc/articles/PMC4396433/ /pubmed/25884009 http://dx.doi.org/10.1093/ofid/ofu122 Text en © The Author 2014. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com.
spellingShingle Brief Reports
Kadkhoda, Kamran
Smart, Gerry
Bacon, Diane
Casselman, Adara
Malloch, Laurie
Kim, John
Seroprevalence of Human T-Cell Lymphotropic Viruses Types 1 and 2 Antibodies in Hepatitis C Virus-Positive Patients: Manitoba, Canada, 2012–2014
title Seroprevalence of Human T-Cell Lymphotropic Viruses Types 1 and 2 Antibodies in Hepatitis C Virus-Positive Patients: Manitoba, Canada, 2012–2014
title_full Seroprevalence of Human T-Cell Lymphotropic Viruses Types 1 and 2 Antibodies in Hepatitis C Virus-Positive Patients: Manitoba, Canada, 2012–2014
title_fullStr Seroprevalence of Human T-Cell Lymphotropic Viruses Types 1 and 2 Antibodies in Hepatitis C Virus-Positive Patients: Manitoba, Canada, 2012–2014
title_full_unstemmed Seroprevalence of Human T-Cell Lymphotropic Viruses Types 1 and 2 Antibodies in Hepatitis C Virus-Positive Patients: Manitoba, Canada, 2012–2014
title_short Seroprevalence of Human T-Cell Lymphotropic Viruses Types 1 and 2 Antibodies in Hepatitis C Virus-Positive Patients: Manitoba, Canada, 2012–2014
title_sort seroprevalence of human t-cell lymphotropic viruses types 1 and 2 antibodies in hepatitis c virus-positive patients: manitoba, canada, 2012–2014
topic Brief Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4396433/
https://www.ncbi.nlm.nih.gov/pubmed/25884009
http://dx.doi.org/10.1093/ofid/ofu122
work_keys_str_mv AT kadkhodakamran seroprevalenceofhumantcelllymphotropicvirusestypes1and2antibodiesinhepatitiscviruspositivepatientsmanitobacanada20122014
AT smartgerry seroprevalenceofhumantcelllymphotropicvirusestypes1and2antibodiesinhepatitiscviruspositivepatientsmanitobacanada20122014
AT bacondiane seroprevalenceofhumantcelllymphotropicvirusestypes1and2antibodiesinhepatitiscviruspositivepatientsmanitobacanada20122014
AT casselmanadara seroprevalenceofhumantcelllymphotropicvirusestypes1and2antibodiesinhepatitiscviruspositivepatientsmanitobacanada20122014
AT mallochlaurie seroprevalenceofhumantcelllymphotropicvirusestypes1and2antibodiesinhepatitiscviruspositivepatientsmanitobacanada20122014
AT kimjohn seroprevalenceofhumantcelllymphotropicvirusestypes1and2antibodiesinhepatitiscviruspositivepatientsmanitobacanada20122014

Ejemplares similares